Yanming Zu

Dr. Zu focuses on liquid dosage forms, specifically oral suspensions and long acting injectables. She is also responsible for overviewing the pharmacokinetic support for biostudy design and other requirements for all products at Abon. Additionally, she manages the 505(b)(2) projects Abon has undertaken. Before Abon, Dr. Zu joined Barr Laboratory in 2001 as a Formulation Scientist and later served as a Senior Scientist and then a Principal Scientist. She joined Abon at its inception as the Director of Formulation R&D, responsible for the generic and proprietary product development. Dr. Zu’s work contributed to multiple ANDAs, including several first to file approvals, and generated several patents, research papers, review articles, and invited presentations.

Dr. Zu received her Ph.D. in Pharmaceutics from the University of Illinois at Chicago. She completed her B.S. in Pharmacy (English) and studied M.S. in Pharmaceutics from Shenyang Pharmaceutical University, China. Dr. Zu is a Registered Pharmacist in New York State. She also holds an M.S. degree in Acupuncture from the Eastern School of Acupuncture and Traditional Medicine.